🔗 Visit the ClinicalTrials.gov page for NCT00712738
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. | Blood | 2005 | 6.07 |
| 2 | Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. | Nat Med | 2007 | 1.73 |
| 3 | Chelation therapy for iron overload. | Curr Gastroenterol Rep | 2007 | 0.87 |
| 4 | Interdependence of cardiac iron and calcium in a murine model of iron overload. | Transl Res | 2010 | 0.85 |